(EMAILWIRE.COM, October 18, 2018 ) Overview:

In the year 2018, Europe Smart Inhaler Market was valued at USD 5.18 Million. By the year 2023, it is expected to reach USD 62.87 Million at pace of 64.77% CAGR.

Smart Inhaler is part of the new digital technology designed to improve the management of respiratory diseases. Smart inhalers are basically respiratory inhalers equipped with a digital sensor. The sensor installed in the inhaler has the ability to track data such as dosing time, monitor inhaler usage and schedule the next dose. Smart Inhalers can generate alerts for daily dosing to the user with the help of smart mobiles that are connected to the sensors via Bluetooth.

View sample and decide: https://www.marketdataforecast.com/market-reports/europe-smart-inhaler-market-6042/request-sample

Underlying Causes

The growth for Smart Inhaler market is driven due to factors like increasing air pollution which causes chronic infections like COPD, and asthma, growing adoption of digitalized medical devices, rising aging population, increasing awareness about Smart inhalers devices among people, and rising healthcare expenditure. In addition, rising focus by major pharmaceutical industries to improve the efficacy of prescribed medicines, advancement of technologies in the medical industry, increasing investments for R&D activities, and introduction of advanced devices which is expected to drive the market growth. However, high costs of devices, limitations in data privacy, and limited availability of devices are expected to decline the growth rate for Europe Smart Inhaler Market during the forecast period.

To know more read: https://www.marketdataforecast.com/market-reports/europe-smart-inhaler-market-6042/

Geographic Segmentation:

Based on geography the Europe Smart Inhaler market has been primarily divided into United Kingdom, France, Spain, Italy and Germany. Germany holds the largest market share in the Europe Smart Inhaler Market followed by U.K. and France due to favorable reimbursement, and increasing demand for Smart Inhaler devices are the driving factors in this region.

Get your customized report: https://www.marketdataforecast.com/market-reports/europe-smart-inhaler-market-6042/customize-report

Key Players:

Leading companies for Europe Smart Inhaler market are Vectura Group plc, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca plc, Adherium Limited, Cohero Health, LLC, Propeller Health, GlaxoSmithKline plc and OPKO Health, Inc.

About MarketDataForecast™

Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.

Contact Information:

Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank Filmnagar Branch, B 44, Rd Number 3, Journalist Colony, Hyderabad, Telangana 500033.

Phone: +1-888-702-9626

Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results